HCP
MRK icon

Hexagon Capital Partners’s Merck MRK Stock Holding History

Hexagon Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.58M Sell
13,098
-2,154
-14% -$249K 0.23% 41
2025
Q4 		$1.61M Buy
15,252
+762
+5% +$71.5K 0.3% 32
2025
Q3 		$1.22M Buy
14,490
+355
+3% +$29.2K 0.24% 40
2025
Q2 		$1.12M Buy
14,135
+3,554
+34% +$283K 0.25% 40
2025
Q1 		$950K Buy
10,581
+4,090
+63% +$382K 0.18% 60
2024
Q4 		$646K Buy
6,491
+1,148
+21% +$118K 0.12% 82
2024
Q3 		$607K Sell
5,343
-170
-3% -$20.2K 0.12% 82
2024
Q2 		$682K Buy
5,513
+375
+7% +$48.3K 0.15% 74
2024
Q1 		$678K Sell
5,138
-566
-10% -$69.8K 0.15% 70
2023
Q4 		$622K Buy
5,704
+2,108
+59% +$219K 0.15% 73
2023
Q3 		$370K Sell
3,596
-406
-10% -$43.8K 0.1% 104
2023
Q2 		$462K Sell
4,002
-170
-4% -$19.3K 0.12% 86
2023
Q1 		$444K Sell
4,172
-972
-19% -$105K 0.12% 87
2022
Q4 		$571K Sell
5,144
-3,536
-41% -$361K 0.17% 65
2022
Q3 		$747K Buy
8,680
+2,593
+43% +$231K 0.22% 49
2022
Q2 		$555K Buy
6,087
+982
+19% +$87.1K 0.17% 73
2022
Q1 		$419K Buy
5,105
+261
+5% +$20.6K 0.11% 109
2021
Q4 		$371K Buy
4,844
+335
+7% +$26.7K 0.1% 120
2021
Q3 		$339K Sell
4,509
-819
-15% -$62.3K 0.1% 111
2021
Q2 		$414K Buy
5,328
+1,165
+28% +$86.7K 0.11% 95
2021
Q1 		$306K Sell
4,163
-34
-0.8% -$2.51K 0.08% 109
2020
Q4 		$327K Buy
4,197
+14
+0.3% +$1.07K 0.1% 87
2020
Q3 		$306K Buy
+4,183
New +$328K 0.1% 91

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hexagon Capital Partners's MRK Position: Q1 2026 in Review

Hexagon Capital Partners reduced its Merck (MRK) stake by 14% in Q1 2026, selling an estimated $249K and leaving 13,098 shares worth $1.58M. The position accounts for 0.23% of the portfolio, ranked #41.

Hexagon Capital Partners first reported a position in MRK in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.61M in Q4 2025. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Hexagon Capital Partners held 13,098 shares of Merck worth $1.58M as of Q1 2026.
  • Hexagon Capital Partners sold 2,154 Merck shares in Q1 2026, an estimated $249K.
  • Merck made up 0.23% of Hexagon Capital Partners's portfolio in Q1 2026, its #41 holding.
  • Hexagon Capital Partners first reported a position in Merck in Q3 2020 and has held it in 23 quarters since.
  • Hexagon Capital Partners's Merck position peaked at $1.61M in Q4 2025.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Hexagon Capital Partners's 13F filing for Q1 2026, filed 5 May 2026.